These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24651522)

  • 1. Integrative ChIP-seq/microarray analysis identifies a CTNNB1 target signature enriched in intestinal stem cells and colon cancer.
    Watanabe K; Biesinger J; Salmans ML; Roberts BS; Arthur WT; Cleary M; Andersen B; Xie X; Dai X
    PLoS One; 2014; 9(3):e92317. PubMed ID: 24651522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-Specific Effects of Reduced β-catenin Expression on Adenomatous Polyposis Coli Mutation-Instigated Tumorigenesis in Mouse Colon and Ovarian Epithelium.
    Feng Y; Sakamoto N; Wu R; Liu JY; Wiese A; Green ME; Green M; Akyol A; Roy BC; Zhai Y; Cho KR; Fearon ER
    PLoS Genet; 2015 Nov; 11(11):e1005638. PubMed ID: 26528816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells.
    Yochum GS; McWeeney S; Rajaraman V; Cleland R; Peters S; Goodman RH
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3324-9. PubMed ID: 17360646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch1 counteracts WNT/β-catenin signaling through chromatin modification in colorectal cancer.
    Kim HA; Koo BK; Cho JH; Kim YY; Seong J; Chang HJ; Oh YM; Stange DE; Park JG; Hwang D; Kong YY
    J Clin Invest; 2012 Sep; 122(9):3248-59. PubMed ID: 22863622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness.
    Grinat J; Heuberger J; Vidal RO; Goveas N; Kosel F; Berenguer-Llergo A; Kranz A; Wulf-Goldenberg A; Behrens D; Melcher B; Sauer S; Vieth M; Batlle E; Stewart AF; Birchmeier W
    Nat Commun; 2020 Dec; 11(1):6422. PubMed ID: 33349639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer.
    Takahashi M; Nakamura Y; Obama K; Furukawa Y
    Int J Oncol; 2005 Dec; 27(6):1483-7. PubMed ID: 16273202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq.
    Bottomly D; Kyler SL; McWeeney SK; Yochum GS
    Nucleic Acids Res; 2010 Sep; 38(17):5735-45. PubMed ID: 20460455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
    World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
    Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
    Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of the intestinal stem cell signature gene SMOC-2 is required for L1-mediated colon cancer progression.
    Shvab A; Haase G; Ben-Shmuel A; Gavert N; Brabletz T; Dedhar S; Ben-Ze'ev A
    Oncogene; 2016 Feb; 35(5):549-57. PubMed ID: 25915847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
    Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
    Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.
    Lachenmayer A; Alsinet C; Savic R; Cabellos L; Toffanin S; Hoshida Y; Villanueva A; Minguez B; Newell P; Tsai HW; Barretina J; Thung S; Ward SC; Bruix J; Mazzaferro V; Schwartz M; Friedman SL; Llovet JM
    Clin Cancer Res; 2012 Sep; 18(18):4997-5007. PubMed ID: 22811581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of endoplasmic reticulum stress by deletion of Grp78 depletes Apc mutant intestinal epithelial stem cells.
    van Lidth de Jeude JF; Meijer BJ; Wielenga MCB; Spaan CN; Baan B; Rosekrans SL; Meisner S; Shen YH; Lee AS; Paton JC; Paton AW; Muncan V; van den Brink GR; Heijmans J
    Oncogene; 2017 Jun; 36(24):3397-3405. PubMed ID: 27819675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt signaling inhibits Forkhead box O3a-induced transcription and apoptosis through up-regulation of serum- and glucocorticoid-inducible kinase 1.
    Dehner M; Hadjihannas M; Weiske J; Huber O; Behrens J
    J Biol Chem; 2008 Jul; 283(28):19201-10. PubMed ID: 18487207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxf2 in intestinal fibroblasts reduces numbers of Lgr5(+) stem cells and adenoma formation by inhibiting Wnt signaling.
    Nik AM; Reyahi A; Pontén F; Carlsson P
    Gastroenterology; 2013 May; 144(5):1001-11. PubMed ID: 23376422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive feedback regulation between phospholipase D and Wnt signaling promotes Wnt-driven anchorage-independent growth of colorectal cancer cells.
    Kang DW; Min do S
    PLoS One; 2010 Aug; 5(8):e12109. PubMed ID: 20711340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the potential marker for intestinal cells, Bmi1, by β-catenin and the zinc finger protein KLF4: implications for colon cancer.
    Yu T; Chen X; Zhang W; Colon D; Shi J; Napier D; Rychahou P; Lu W; Lee EY; Weiss HL; Evers BM; Liu C
    J Biol Chem; 2012 Feb; 287(6):3760-8. PubMed ID: 22170051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.
    Kim HJ; Moon SJ; Kim SH; Heo K; Kim JH
    Cell Death Dis; 2018 Aug; 9(8):831. PubMed ID: 30082743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative multi-omics analysis of a colon cancer cell line with heterogeneous Wnt activity revealed RUNX2 as an epigenetic regulator of EMT.
    Yi H; Li G; Long Y; Liang W; Cui H; Zhang B; Tan Y; Li Y; Shen L; Deng D; Tang Y; Mao C; Tian S; Cai Y; Zhu Q; Hu Y; Chen W; Fang L
    Oncogene; 2020 Jul; 39(28):5152-5164. PubMed ID: 32535615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.